SCHEMBL167094

SCHEMBL167094

Cc1cc(Nc2nc(C(F)(F)c3ccc(F)cn3)nc3ccsc23)n[nH]1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAK1 Q13153 3/20 0.48
JAK2 O60674 12/20 0.43
JAK3 P52333 11/20 0.43
NTRK1 P04629 3/20 0.40
CDK2 P24941 2/20 0.40
MUSK O15146 1/20 0.40
LCK P06239 1/20 0.40
RET P07949 1/20 0.40
FGFR3 P22607 1/20 0.40
CCNE1 P24864 1/20 0.40
FLT3 P36888 1/20 0.40
PTK2B Q14289 1/20 0.40
AURKB Q96GD4 2/20 0.40
STAT5B P51692 1/20 0.40
AURKA O14965 1/20 0.39
CYP3A4 P08684 3/20 0.39
CYP2C8 P10632 3/20 0.39
CYP2C9 P11712 3/20 0.39
JAK1 P23458 3/20 0.39
TYK2 P29597 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL166273 0.86 PAK1 (0.51) PAK1JAK2JAK3NTRK1LCK
SCHEMBL163559 0.84 AURKA (0.56) JAK2JAK3NTRK1AURKBAURKA
SCHEMBL165657 0.83 JAK2 (0.56) JAK2JAK3NTRK1AURKBAURKA
SCHEMBL160401 0.83 NTRK1 (0.53) JAK2JAK3NTRK1AURKBAURKA
SCHEMBL162144 0.81 NTRK1 (0.54) JAK2JAK3NTRK1AURKBAURKA
SCHEMBL163318 0.81 NTRK1 (0.54) JAK2JAK3NTRK1CDK2MUSK
SCHEMBL10284854 0.81 AURKA (0.48) JAK2JAK3NTRK1CDK2MUSK
SCHEMBL161955 0.80 AURKA (0.47) JAK2JAK3NTRK1CDK2MUSK
SCHEMBL159058 0.80 AURKA (0.55) JAK2JAK3NTRK1AURKBAURKA
SCHEMBL174212 0.79 NTRK1 (0.46) JAK2JAK3NTRK1AURKBAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611812-A1 THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2013-07-10 EP claimed
WO-2012030894-A1 THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2012-03-08 WO claimed
EP-2611812-A1 THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2013-07-10 EP disclosed
WO-2012030894-A1 THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2012-03-08 WO disclosed
WO-2012030894-A1 THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2012-03-08 WO disclosed